Schedule 13G ownership disclosure

CYCLERION THERAPEUTICS INC

Security class unavailable · CUSIP: 23255M105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,157,601
Percent of class
16.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-000260
Form type
SC 13G
Filer
Cyclerion Therapeutics, Inc.
CIK
CIK 1755237
Filed
Jan 13, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub